Abstract
The expression of HLA class I antigens was studied in 99 primary tumour (colorectal, gastric and laryngeal carcinomas) and 57 autologous metastases using immunohistological techniques and monoclonal antibodies against class I monomorphic determinants, HLA-B isotypic determinants and HLA polymorphic determinants. Fourteen per cent of colorectal, 9.6% of gastric and 20% of laryngeal carcinomas completely lacked class I molecules. Selective losses of HLA-B antigens were also detected in 8.8, 3.4 and 5.8% of these tumours respectively. Taking into account complete and selective loss of HLA-B the average alteration in the class I molecules expression totalled 21%. The comparison of class I expression between primary tumours and autologous metastases showed differences in 24% of the patients. These differences consisted mainly in a decrease of class I expression by metastases. Nevertheless, four types of divergence were detected in laryngeal carcinomas, namely: +/-, +/+, -/+, -/-. In addition, a clear correlation between degree of differentiation and class I expression was observed in laryngeal tumours. Finally, when class I gene RFLPs were compared with DNA from 15 tumours and autologous normal mucosa or peripheral lymphocytes, no differences were detected between these samples.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
López-Nevot, M., Esteban, F., Ferrón, A. et al. HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas. Br J Cancer 59, 221–226 (1989). https://doi.org/10.1038/bjc.1989.45
Issue Date:
DOI: https://doi.org/10.1038/bjc.1989.45
This article is cited by
-
HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy
Cellular & Molecular Immunology (2021)
-
HLA class I alterations in breast carcinoma are associated with a high frequency of the loss of heterozygosity at chromosomes 6 and 15
Immunogenetics (2018)
-
Down-regulation of HLA-A mRNA in peripheral blood mononuclear cell of colorectal cancer
International Journal of Colorectal Disease (2012)
-
Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation
BMC Urology (2011)
-
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
Immunogenetics (2008)